Expression of a Functional Mx1 Protein Is Essential for the Ability of RIG-I Agonist Prophylaxis to Provide Potent and Long-Lasting Protection in a Mouse Model of Influenza A Virus Infection

RIG-I is an innate sensor of RNA virus infection and its activation induces interferon-stimulated genes (ISGs). In vitro studies using human cells have demonstrated the ability of synthetic RIG-I agonists (3pRNA) to inhibit IAV replication. However, in mouse models of IAV the effectiveness of 3pRNA...

Full description

Saved in:
Bibliographic Details
Published inViruses Vol. 14; no. 7; p. 1547
Main Authors Schwab, Lara S. U, Villalón-Letelier, Fernando, Tessema, Melkamu B, Londrigan, Sarah L, Brooks, Andrew G, Hurt, Aeron, Coch, Christoph, Zillinger, Thomas, Hartmann, Gunther, Reading, Patrick C
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 15.07.2022
MDPI
Subjects
Agonists
Analysis
Animal models
Animals
Care and treatment
Dengue fever
Diagnosis
Disease prevention
Fibroblasts
Immunocompromised host
Inbreeding
Infections
Influenza
Influenza A
innate immunity
Interferon
Intravenous administration
mouse model
Myxoma
Myxovirus resistance proteins
Prophylaxis
Proteins
RIG-I
RNA viruses
Rodents
Severe acute respiratory syndrome coronavirus 2
Transcription activation
Viruses
Australia
United States > US
Melbourne Victoria Australia
Online AccessGet full text

Cover

Abstract RIG-I is an innate sensor of RNA virus infection and its activation induces interferon-stimulated genes (ISGs). In vitro studies using human cells have demonstrated the ability of synthetic RIG-I agonists (3pRNA) to inhibit IAV replication. However, in mouse models of IAV the effectiveness of 3pRNA reported to date differs markedly between studies. Myxoma resistance (Mx)1 is an ISG protein which mediates potent anti-IAV activity, however most inbred mouse strains do not express a functional Mx1. Herein, we utilised C57BL/6 mice that do (B6.A2G-Mx1) and do not (B6-WT) express functional Mx1 to assess the ability of prophylactic 3pRNA treatment to induce ISGs and to protect against subsequent IAV infection. In vitro, 3pRNA treatment of primary lung cells from B6-WT and B6.A2G-Mx1 mice resulted in ISG induction however inhibition of IAV infection was more potent in cells from B6.A2G-Mx1 mice. In vivo, a single intravenous injection of 3pRNA resulted in ISG induction in lungs of both B6-WT and B6.A2G-Mx1 mice, however potent and long-lasting protection against subsequent IAV challenge was only observed in B6.A2G-Mx1 mice. Thus, despite broad ISG induction, expression of a functional Mx1 is critical for potent and long-lasting RIG-I agonist-mediated protection in the mouse model of IAV infection.
AbstractList RIG-I is an innate sensor of RNA virus infection and its activation induces interferon-stimulated genes (ISGs). In vitro studies using human cells have demonstrated the ability of synthetic RIG-I agonists (3pRNA) to inhibit IAV replication. However, in mouse models of IAV the effectiveness of 3pRNA reported to date differs markedly between studies. Myxoma resistance (Mx)1 is an ISG protein which mediates potent anti-IAV activity, however most inbred mouse strains do not express a functional Mx1. Herein, we utilised C57BL/6 mice that do (B6.A2G-Mx1) and do not (B6-WT) express functional Mx1 to assess the ability of prophylactic 3pRNA treatment to induce ISGs and to protect against subsequent IAV infection. In vitro, 3pRNA treatment of primary lung cells from B6-WT and B6.A2G-Mx1 mice resulted in ISG induction however inhibition of IAV infection was more potent in cells from B6.A2G-Mx1 mice. In vivo, a single intravenous injection of 3pRNA resulted in ISG induction in lungs of both B6-WT and B6.A2G-Mx1 mice, however potent and long-lasting protection against subsequent IAV challenge was only observed in B6.A2G-Mx1 mice. Thus, despite broad ISG induction, expression of a functional Mx1 is critical for potent and long-lasting RIG-I agonist-mediated protection in the mouse model of IAV infection.
RIG-I is an innate sensor of RNA virus infection and its activation induces interferon-stimulated genes (ISGs). In vitro studies using human cells have demonstrated the ability of synthetic RIG-I agonists (3pRNA) to inhibit IAV replication. However, in mouse models of IAV the effectiveness of 3pRNA reported to date differs markedly between studies. Myxoma resistance (Mx)1 is an ISG protein which mediates potent anti-IAV activity, however most inbred mouse strains do not express a functional Mx1. Herein, we utilised C57BL/6 mice that do (B6.A2G- Mx1 ) and do not (B6-WT) express functional Mx1 to assess the ability of prophylactic 3pRNA treatment to induce ISGs and to protect against subsequent IAV infection. In vitro, 3pRNA treatment of primary lung cells from B6-WT and B6.A2G- Mx1 mice resulted in ISG induction however inhibition of IAV infection was more potent in cells from B6.A2G- Mx1 mice. In vivo, a single intravenous injection of 3pRNA resulted in ISG induction in lungs of both B6-WT and B6.A2G- Mx1 mice, however potent and long-lasting protection against subsequent IAV challenge was only observed in B6.A2G- Mx1 mice. Thus, despite broad ISG induction, expression of a functional Mx1 is critical for potent and long-lasting RIG-I agonist-mediated protection in the mouse model of IAV infection.
Audience Academic
Author Villalón-Letelier, Fernando
Hartmann, Gunther
Tessema, Melkamu B
Brooks, Andrew G
Coch, Christoph
Schwab, Lara S. U
Londrigan, Sarah L
Hurt, Aeron
Zillinger, Thomas
Reading, Patrick C
AuthorAffiliation 3 WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, VIC 3000, Australia; aeron.hurt@roche.com
1 Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, VIC 3000, Australia; lara.schwab@unimelb.edu.au (L.S.U.S.); fernandojavier.villalon@mssm.edu (F.V.-L.); melkamubezie.tessema@unimelb.edu.au (M.B.T.); sarahll@unimelb.edu.au (S.L.L.); agbrooks@unimelb.edu.au (A.G.B.)
2 Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany; ccoch@gmx.net (C.C.); zillinger@uni-bonn.de (T.Z.); gunther.hartmann@uni-bonn.de (G.H.)
AuthorAffiliation_xml – name: 1 Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, VIC 3000, Australia; lara.schwab@unimelb.edu.au (L.S.U.S.); fernandojavier.villalon@mssm.edu (F.V.-L.); melkamubezie.tessema@unimelb.edu.au (M.B.T.); sarahll@unimelb.edu.au (S.L.L.); agbrooks@unimelb.edu.au (A.G.B.)
– name: 3 WHO Collaborating Centre for Reference and Research on Influenza, Victorian Infectious Diseases Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth St, Melbourne, VIC 3000, Australia; aeron.hurt@roche.com
– name: 2 Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany; ccoch@gmx.net (C.C.); zillinger@uni-bonn.de (T.Z.); gunther.hartmann@uni-bonn.de (G.H.)
Author_xml – sequence: 1
  fullname: Schwab, Lara S. U
– sequence: 2
  fullname: Villalón-Letelier, Fernando
– sequence: 3
  fullname: Tessema, Melkamu B
– sequence: 4
  fullname: Londrigan, Sarah L
– sequence: 5
  fullname: Brooks, Andrew G
– sequence: 6
  fullname: Hurt, Aeron
– sequence: 7
  fullname: Coch, Christoph
– sequence: 8
  fullname: Zillinger, Thomas
– sequence: 9
  fullname: Hartmann, Gunther
– sequence: 10
  fullname: Reading, Patrick C
BookMark eNptksuO0zAUhiM0iLnAgjewxIZZZPA1sTdI1agzROqIEQK2kZPYqavULrZTtTwcz4bTjgaKkCVffv_nO_LxuczOrLMqy94ieEOIgB-2iMISMVq-yC6QECKnArGzv_bn2WUIKwiLQsDyVXZOGE8qLi-yX_PdxqsQjLPAaSDB3WjbmE5yAA87BB69i8pYUAUwD0HZaNKFdh7EpQKzxgwm7qfAL9V9XoFZ76wJcYraLPeD3JkAopuOW9Mp8JhYNgJpO7Bwts8XMkRj-2OSQ1aQUknw4Mag0typYWJXVg-jsj8lmIHvxo9hUo7-19lLLYeg3jytV9m3u_nX20_54vN9dTtb5C2lJOYEcsp1IQknuMNMs5KRTmilWlpI3TQaQixEyYXQutQMY45EgSmCSZGwKchVVh25nZOreuPNWvp97aSpD4LzfS19NO2gakl5hwgkbYk1LRmSneJcc1hKiiTETWJ9PLI2Y7NWXZtK4uVwAj29sWZZ925bC4IEYTAB3j8BvPsxqhDrtQmtGgZpVapcjQvBMGewQMn67h_ryo0-fe7BRaEoCSr-uHqZHmCsdilvO0HrWYlT0XgBWXLd_MeVRqfWpk0dqU3STwKujwGtdyF4pZ_fiGA9NW793LjkN-cI3zo
CitedBy_id crossref_primary_10_1038_s41598_024_63314_2
Cites_doi 10.1038/mt.2010.222
10.1002/0471729256.mc15g01s3
10.1128/MMBR.00024-13
10.1128/jvi.66.7.4154-4160.1992
10.1128/jvi.00419-22
10.1128/JVI.03114-13
10.1016/j.cyto.2016.11.015
10.1016/j.vaccine.2016.11.060
10.1016/j.omtn.2022.02.008
10.1016/j.ajpath.2012.12.022
10.1016/S0021-9258(18)89666-1
10.1084/jem.20161033
10.1016/j.coviro.2011.10.008
10.1016/S0168-9525(02)00007-0
10.1128/jvi.69.4.2596-2601.1995
10.1016/j.ymthe.2017.07.003
10.3390/cells10092258
10.1128/jvi.66.4.2564-2569.1992
10.1016/j.immuni.2011.05.003
10.1016/j.tim.2014.12.003
10.1186/1743-422X-8-468
10.1126/science.1132505
10.3109/08830185.2010.529976
10.1128/JVI.00837-21
10.1084/jem.20211818
10.4049/jimmunol.90.6.942
10.1158/1535-7163.MCT-14-0913
10.1038/nature13590
10.1128/JVI.01682-12
10.1007/BF01241985
10.1128/JVI.01116-07
10.1007/978-1-4939-8570-8_5
10.1073/pnas.0914561107
10.1371/annotation/8fa70b21-32e7-4ed3-b397-ab776b5bbf30
10.1006/meth.2001.1262
10.1128/JVI.00845-15
10.4049/jimmunol.1401625
10.1016/0042-6822(62)90297-0
10.3389/fmicb.2016.00326
10.1084/jem.154.1.199
10.1186/1743-422X-7-102
10.1016/j.antiviral.2020.104751
10.1146/annurev.biochem.76.050106.093909
10.1016/j.immuni.2009.05.008
ContentType Journal Article
Copyright COPYRIGHT 2022 MDPI AG
2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: COPYRIGHT 2022 MDPI AG
– notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
3V.
7U9
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/v14071547
DatabaseName CrossRef
ProQuest Central (Corporate)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
Publicly Available Content (ProQuest)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1999-4915
ExternalDocumentID oai_doaj_org_article_a48d1303c72f4751ade88f807a41a02b
A723838605
10_3390_v14071547
GeographicLocations Australia
United States--US
Melbourne Victoria Australia
GeographicLocations_xml – name: Australia
– name: Melbourne Victoria Australia
– name: United States--US
GrantInformation_xml – fundername: Deutsche Forschungsgemeinschaft
  grantid: 369799452—TRR237
– fundername: Australian Government Department of Health
– fundername: Germany’s Excellence Strategy
  grantid: EXC2151–390873048
– fundername: National Health and Medical Research Council (NHMRC) of Australia
  grantid: APP1143154
– fundername: German Center for Infectious Diseases (DZIF)
  grantid: 07.834_00
GroupedDBID ---
2WC
3V.
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
AFKRA
AFPKN
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
DIK
E3Z
EBD
ESTFP
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
ISR
ITC
KQ8
LK8
M1P
M48
M7P
MODMG
M~E
O5R
O5S
OK1
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RPM
TR2
TUS
UKHRP
RIG
7U9
7XB
8FK
AZQEC
COVID
DWQXO
GNUQQ
H94
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c443t-30848f6a3832d25f5753d9feec46afbbf002997899ff7f52281962410899a0b63
IEDL.DBID RPM
ISSN 1999-4915
IngestDate Tue Oct 22 15:13:02 EDT 2024
Tue Sep 17 21:21:38 EDT 2024
Wed Dec 04 14:52:52 EST 2024
Sat Nov 09 10:48:55 EST 2024
Tue Nov 19 21:42:33 EST 2024
Wed Nov 13 00:17:01 EST 2024
Fri Dec 06 08:53:31 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c443t-30848f6a3832d25f5753d9feec46afbbf002997899ff7f52281962410899a0b63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3619-9800
0000-0003-0989-4971
0000-0002-8860-5308
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319350/
PMID 35891527
PQID 2694097316
PQPubID 2032319
ParticipantIDs doaj_primary_oai_doaj_org_article_a48d1303c72f4751ade88f807a41a02b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9319350
proquest_miscellaneous_2695285061
proquest_journals_2694097316
gale_infotracmisc_A723838605
gale_infotracacademiconefile_A723838605
crossref_primary_10_3390_v14071547
PublicationCentury 2000
PublicationDate 20220715
PublicationDateYYYYMMDD 2022-07-15
PublicationDate_xml – month: 7
  year: 2022
  text: 20220715
  day: 15
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Viruses
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Tessema (ref_42) 2022; 96
Schlee (ref_4) 2009; 31
Szretter (ref_23) 2006; 3
Staeheli (ref_38) 1988; 8
Hornung (ref_3) 2006; 314
Lindenmann (ref_41) 1966; 19
Ranjan (ref_10) 2010; 7
Jeeninga (ref_25) 2017; 35
Chiang (ref_9) 2015; 89
Brauer (ref_21) 2015; 97
Lindenmann (ref_40) 1963; 90
Livak (ref_30) 2001; 25
Pavlovic (ref_35) 1992; 66
Xue (ref_22) 2016; 7
Lambrecht (ref_46) 2011; 19
Mifsud (ref_24) 2020; 176
Dai (ref_27) 2011; 8
Loo (ref_44) 2011; 34
Mao (ref_12) 2022; 219
Haller (ref_14) 2015; 23
Tumpey (ref_16) 2007; 81
Deeg (ref_17) 2017; 214
Lindenmann (ref_32) 1962; 16
Meischel (ref_43) 2021; 95
Chang (ref_37) 2007; 76
Penkert (ref_28) 2017; 91
Edelman (ref_20) 2018; 1809
Olagnier (ref_7) 2014; 88
Verhelst (ref_33) 2013; 77
Verhelst (ref_36) 2012; 86
Staeheli (ref_26) 1985; 260
Kumar (ref_2) 2011; 30
Coch (ref_11) 2017; 25
Chakravarthy (ref_31) 2010; 107
ref_1
Huang (ref_34) 1992; 66
Marx (ref_13) 2022; 27
Haller (ref_15) 1981; 154
Bonhomme (ref_19) 2003; 19
Bacsi (ref_45) 2014; 193
ref_8
Song (ref_18) 2013; 182
Haller (ref_39) 1995; 69
Goubau (ref_5) 2014; 514
Schoggins (ref_6) 2011; 1
Ayllon (ref_29) 2015; 14
References_xml – volume: 19
  start-page: 602
  year: 2011
  ident: ref_46
  article-title: Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses
  publication-title: Mol. Ther.
  doi: 10.1038/mt.2010.222
  contributor:
    fullname: Lambrecht
– volume: 3
  start-page: 15G. 1.1
  year: 2006
  ident: ref_23
  article-title: Influenza: Propagation, quantification, and storage
  publication-title: Curr. Protoc. Microbiol.
  doi: 10.1002/0471729256.mc15g01s3
  contributor:
    fullname: Szretter
– volume: 77
  start-page: 551
  year: 2013
  ident: ref_33
  article-title: Mx proteins: Antiviral gatekeepers that restrain the uninvited
  publication-title: Microbiol. Mol. Biol. Rev.
  doi: 10.1128/MMBR.00024-13
  contributor:
    fullname: Verhelst
– volume: 66
  start-page: 4154
  year: 1992
  ident: ref_34
  article-title: Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein
  publication-title: J. Virol.
  doi: 10.1128/jvi.66.7.4154-4160.1992
  contributor:
    fullname: Huang
– volume: 96
  start-page: e0041922
  year: 2022
  ident: ref_42
  article-title: Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression In Vitro and Prevents Lesion Formation in the Mouse Zosteriform Model
  publication-title: J. Virol.
  doi: 10.1128/jvi.00419-22
  contributor:
    fullname: Tessema
– volume: 88
  start-page: 4180
  year: 2014
  ident: ref_7
  article-title: Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response
  publication-title: J. Virol.
  doi: 10.1128/JVI.03114-13
  contributor:
    fullname: Olagnier
– volume: 91
  start-page: 1
  year: 2017
  ident: ref_28
  article-title: Vitamin A differentially regulates cytokine expression in respiratory epithelial and macrophage cell lines
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2016.11.015
  contributor:
    fullname: Penkert
– volume: 35
  start-page: 46
  year: 2017
  ident: ref_25
  article-title: ViroSpot microneutralization assay for antigenic characterization of human influenza viruses
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.11.060
  contributor:
    fullname: Jeeninga
– volume: 27
  start-page: 1225
  year: 2022
  ident: ref_13
  article-title: RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection
  publication-title: Mol. Ther. Nucleic Acids
  doi: 10.1016/j.omtn.2022.02.008
  contributor:
    fullname: Marx
– volume: 182
  start-page: 1308
  year: 2013
  ident: ref_18
  article-title: Early regulation of viral infection reduces inflammation and rescues mx-positive mice from lethal avian influenza infection
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2012.12.022
  contributor:
    fullname: Song
– volume: 260
  start-page: 1821
  year: 1985
  ident: ref_26
  article-title: Polyclonal and monoclonal antibodies to the interferon-inducible protein Mx of influenza virus-resistant mice
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)89666-1
  contributor:
    fullname: Staeheli
– volume: 214
  start-page: 1239
  year: 2017
  ident: ref_17
  article-title: In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20161033
  contributor:
    fullname: Deeg
– volume: 1
  start-page: 519
  year: 2011
  ident: ref_6
  article-title: Interferon-stimulated genes and their antiviral effector functions
  publication-title: Curr. Opin. Virol.
  doi: 10.1016/j.coviro.2011.10.008
  contributor:
    fullname: Schoggins
– volume: 19
  start-page: 24
  year: 2003
  ident: ref_19
  article-title: Wild mice: An ever-increasing contribution to a popular mammalian model
  publication-title: Trends Genet.
  doi: 10.1016/S0168-9525(02)00007-0
  contributor:
    fullname: Bonhomme
– volume: 69
  start-page: 2596
  year: 1995
  ident: ref_39
  article-title: Tick-borne thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1
  publication-title: J. Virol.
  doi: 10.1128/jvi.69.4.2596-2601.1995
  contributor:
    fullname: Haller
– volume: 25
  start-page: 2093
  year: 2017
  ident: ref_11
  article-title: RIG-I Activation Protects and Rescues from Lethal Influenza Virus Infection and Bacterial Superinfection
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2017.07.003
  contributor:
    fullname: Coch
– ident: ref_1
  doi: 10.3390/cells10092258
– volume: 66
  start-page: 2564
  year: 1992
  ident: ref_35
  article-title: Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle
  publication-title: J. Virol.
  doi: 10.1128/jvi.66.4.2564-2569.1992
  contributor:
    fullname: Pavlovic
– volume: 34
  start-page: 680
  year: 2011
  ident: ref_44
  article-title: Immune signaling by RIG-I-like receptors
  publication-title: Immunity
  doi: 10.1016/j.immuni.2011.05.003
  contributor:
    fullname: Loo
– volume: 23
  start-page: 154
  year: 2015
  ident: ref_14
  article-title: Mx GTPases: Dynamin-like antiviral machines of innate immunity
  publication-title: Trends Microbiol.
  doi: 10.1016/j.tim.2014.12.003
  contributor:
    fullname: Haller
– volume: 8
  start-page: 468
  year: 2011
  ident: ref_27
  article-title: ISG15 facilitates cellular antiviral response to dengue and west nile virus infection in vitro
  publication-title: Virol. J.
  doi: 10.1186/1743-422X-8-468
  contributor:
    fullname: Dai
– volume: 314
  start-page: 994
  year: 2006
  ident: ref_3
  article-title: 5′-Triphosphate RNA is the ligand for RIG-I
  publication-title: Science
  doi: 10.1126/science.1132505
  contributor:
    fullname: Hornung
– volume: 30
  start-page: 16
  year: 2011
  ident: ref_2
  article-title: Pathogen recognition by the innate immune system
  publication-title: Int. Rev. Immunol.
  doi: 10.3109/08830185.2010.529976
  contributor:
    fullname: Kumar
– volume: 95
  start-page: e00837-21
  year: 2021
  ident: ref_43
  article-title: IFITM proteins that restrict the early stages of respiratory virus infection do not influence late-stage replication
  publication-title: J. Virol.
  doi: 10.1128/JVI.00837-21
  contributor:
    fullname: Meischel
– volume: 219
  start-page: e20211818
  year: 2022
  ident: ref_12
  article-title: A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20211818
  contributor:
    fullname: Mao
– volume: 90
  start-page: 942
  year: 1963
  ident: ref_40
  article-title: The Resistance of A2G Mice to Myxoviruses
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.90.6.942
  contributor:
    fullname: Lindenmann
– volume: 14
  start-page: 1247
  year: 2015
  ident: ref_29
  article-title: Enhancement of the Proapoptotic Properties of Newcastle Disease Virus Promotes Tumor Remission in Syngeneic Murine Cancer Models
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-14-0913
  contributor:
    fullname: Ayllon
– volume: 514
  start-page: 372
  year: 2014
  ident: ref_5
  article-title: Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates
  publication-title: Nature
  doi: 10.1038/nature13590
  contributor:
    fullname: Goubau
– volume: 86
  start-page: 13445
  year: 2012
  ident: ref_36
  article-title: Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly
  publication-title: J. Virol.
  doi: 10.1128/JVI.01682-12
  contributor:
    fullname: Verhelst
– volume: 19
  start-page: 1
  year: 1966
  ident: ref_41
  article-title: Further studies on the resistance of mice to myxoviruses
  publication-title: Arch. Gesamte Virusforsch.
  doi: 10.1007/BF01241985
  contributor:
    fullname: Lindenmann
– volume: 81
  start-page: 10818
  year: 2007
  ident: ref_16
  article-title: The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses
  publication-title: J. Virol.
  doi: 10.1128/JVI.01116-07
  contributor:
    fullname: Tumpey
– volume: 1809
  start-page: 59
  year: 2018
  ident: ref_20
  article-title: Isolation and Characterization of Mouse Fibroblasts
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-8570-8_5
  contributor:
    fullname: Edelman
– volume: 107
  start-page: 10172
  year: 2010
  ident: ref_31
  article-title: Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0914561107
  contributor:
    fullname: Chakravarthy
– ident: ref_8
  doi: 10.1371/annotation/8fa70b21-32e7-4ed3-b397-ab776b5bbf30
– volume: 25
  start-page: 402
  year: 2001
  ident: ref_30
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
  contributor:
    fullname: Livak
– volume: 89
  start-page: 8011
  year: 2015
  ident: ref_9
  article-title: Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists
  publication-title: J. Virol.
  doi: 10.1128/JVI.00845-15
  contributor:
    fullname: Chiang
– volume: 193
  start-page: 4643
  year: 2014
  ident: ref_45
  article-title: Innate Inflammation Induced by the 8-Oxoguanine DNA Glycosylase-1–KRAS–NF-κB Pathway
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.1401625
  contributor:
    fullname: Bacsi
– volume: 16
  start-page: 203
  year: 1962
  ident: ref_32
  article-title: Resistance of mice to mouse-adapted influenza A virus
  publication-title: Virology
  doi: 10.1016/0042-6822(62)90297-0
  contributor:
    fullname: Lindenmann
– volume: 8
  start-page: 4518
  year: 1988
  ident: ref_38
  article-title: Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation
  publication-title: Mol. Cell. Biol.
  contributor:
    fullname: Staeheli
– volume: 7
  start-page: 326
  year: 2016
  ident: ref_22
  article-title: Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin Mutations
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2016.00326
  contributor:
    fullname: Xue
– volume: 97
  start-page: e52421
  year: 2015
  ident: ref_21
  article-title: Influenza virus propagation in embryonated chicken eggs
  publication-title: J. Vis. Exp.
  contributor:
    fullname: Brauer
– volume: 154
  start-page: 199
  year: 1981
  ident: ref_15
  article-title: Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.154.1.199
  contributor:
    fullname: Haller
– volume: 7
  start-page: 102
  year: 2010
  ident: ref_10
  article-title: 5′PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication
  publication-title: Virol. J.
  doi: 10.1186/1743-422X-7-102
  contributor:
    fullname: Ranjan
– volume: 176
  start-page: 104751
  year: 2020
  ident: ref_24
  article-title: Prophylaxis of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy
  publication-title: Antivir. Res.
  doi: 10.1016/j.antiviral.2020.104751
  contributor:
    fullname: Mifsud
– volume: 76
  start-page: 51
  year: 2007
  ident: ref_37
  article-title: The Nonsense-Mediated Decay RNA Surveillance Pathway
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev.biochem.76.050106.093909
  contributor:
    fullname: Chang
– volume: 31
  start-page: 25
  year: 2009
  ident: ref_4
  article-title: Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.05.008
  contributor:
    fullname: Schlee
SSID ssj0066907
Score 2.3545165
Snippet RIG-I is an innate sensor of RNA virus infection and its activation induces interferon-stimulated genes (ISGs). In vitro studies using human cells have...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 1547
SubjectTerms Agonists
Analysis
Animal models
Animals
Care and treatment
Dengue fever
Diagnosis
Disease prevention
Fibroblasts
Immunocompromised host
Inbreeding
Infections
Influenza
Influenza A
innate immunity
Interferon
Intravenous administration
mouse model
Myxoma
Myxovirus resistance proteins
Prophylaxis
Proteins
RIG-I
RNA viruses
Rodents
Severe acute respiratory syndrome coronavirus 2
Transcription activation
Viruses
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiKcILWhASJyiJrHzOga0Sxd1UYUo6i2yY7usVDmoyaJtf1x_GzNxdrWBAxeOiV-JZzyesWe-YexdoY1Gw6IJtdIqFKi_hWVqeWiiUitRaNRi6UB_-SU7ORefL9KLvVRf5BPm4YH9xB1LbEBytskTK_I0ltoUhS2iXIpYRokapG-UbI0pL4Mzsvk8jhBHo_74V0x2S0o5VPZ2nwGk_29R_Kd75N5-M3_EHo6KIlT-Ax-ze8Y9Yfd96sibp-xuthldWB20FiTMcYPy53qw3MRwRvgLKweLDmYdBRghnwEqqIAKH1SDR-wNNfy6-BQuoLpsCUGXWuG0X8nNqoO-pUcK04Mz7Mv1IJ2G09ZdhqeyI29pP8gwKuBQEpbtujNA6dWuqO-FT4ByK6GC76vrdUdvfP1n7Hw--_bxJBxzMYSNELwPOeHu20yiQZsgAS1qeVyX1phGZNIqZel6Dy3Sks6ALSp1qGlkqB3QraKMVMafswPXOvOCgeaFTLEjybNGNHTzmMumzLkyQqOhngXs7ZZG9U8PuVGjqUKErHeEDNgHot6uAqFkDy-Qd-qRd-p_8U7A3hPta1rLSOlGjiEJ-J2EilVXlJGNF2jxBexoUhPXYDMt3nJPPcqArqYY4WjIDBawN7tiakl-bc4gSahOmhBoYBywfMJ1kz-blrjVjwEHvETxydPo5f-YikP2IKHADoIMTY_YQX-9Nq9Q3erV62Fl_QbTxCnY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegExIviE8RGOhASDxZS2InTZ5QhlpWtE7VxNDeIid2SqXJGU2KOv44_jbuErcsIPGY-KvNnc9357vfMfYu0UajYVFyXeiCS9TfeBpVghs_1YVMNGqx5NCfn8UnF_LzZXTpHG6NC6vcycROUOu6JB_5EWVc-l2dpQ_X3zlVjaLbVVdC4y47CAORJCN2cDw5W5zvZHFMtl-PJyTQuD_6EZD9ElEtlVunUAfW_69I_jtM8ta5M33IHjiFEbKewo_YHWMfs3t9CcmbJ-zXZOtCWS3UFSiY4kHV-_dgvg1gQTgMKwuzBiYNJRohvwEqqoCKH2RdZOwNDTyffeIzyJY1IenSKPz8V2q7aqCt6ZHS9WCBc9kWlNVwWtslP1UNRU33i3SrAi6lYF5vGgNUZu2K5p71hVB-Ksjg62q9aehN3_8pu5hOvnw84a4mAy-lFC0XhL9fxQoN2xAJWaG2J3RaGVPKWFVFUdE1H1qmKfmCK1TuUOOIUUug20XlF7F4xka2tuY5Ay0SFeFESsSlLOkGcqxKpHBhpEaDPfbY2x2N8useeiNHk4UIme8J6bFjot6-A6Fldy_q9TJ3my9XyHR0VpfjsJLjKFDaJEmV4HoyUH5YeOw90T6nPY2ULpVLTcDfSehYeUaV2USClp_HDgc9cS-Ww-Yd9-ROFjT5H8712Jt9M42k-DZrkCTUJwoJPDDw2HjAdYN_Nmyxq28dHniKYlRE_ov_L_6S3Q8pdYNAQaNDNmrXG_MKFaq2eO12zW8aASMy
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfGEBIvE-NDhA10ICSeAknsfD0gFKaWFa1oQhTtLXJiu1SqnK1JUcsfx9_GXZJWBBCPjT-u7Z1z97PPv2PsZaK0QmBRuqpQhSswfnPT0HBXe6kqRKIwiqUN_emn6HwmPl6FVwdsV2Oz_wPrf0I7qic1Wy1fb26273DBvyXEiZD9zXefUEko4lvsdoAOkTK7pmJ_mBARAOxIhYbdB66oZez_-738Z67kb85nfI8d9VEjZJ2aj9mBtvfZna6O5PYB-zna9PmsFioDEsborbpNPphufLgkMoaFhUkNo5puG6HRAUargNEfZG167JYGfp58cCeQzSui06VRqIOl3CxqaCr6SHf24BLnsg1Iq-CisnP3QtaUOt0JaaUCipIwrda1Bqq1tqS5J101lB8SMvi6WK1retL1f8hm49GXs3O3L8zglkLwxuVEwm8iieg2QG0aDPm4So3WpYikKQpDZ30IT1PaEDYY4WHYEWGoQEeM0isi_ogd2srqxwwUT2SIE0kelaKkY8hYlmnMCy0UovbIYS92OsqvO_6NHHELKTLfK9Jh70l7-w5Emd0-qFbzvF-BuUTLI4ddxoERcehLpZPEJChP-NILCoe9It3nZGqo6VL29xPwexJFVp5ReTaeIPxz2OmgJy7Icti8s558Z885XRj22jJhDnu-b6aRlORmNaqE-oQBMQj6DosHVjf4ZcMWu_jWkoKn-C7loffk_8JP2N2A7m8QM2h4yg6b1Vo_xaiqKZ61a-YXNrMjNQ
  priority: 102
  providerName: Scholars Portal
Title Expression of a Functional Mx1 Protein Is Essential for the Ability of RIG-I Agonist Prophylaxis to Provide Potent and Long-Lasting Protection in a Mouse Model of Influenza A Virus Infection
URI https://www.proquest.com/docview/2694097316
https://search.proquest.com/docview/2695285061
https://pubmed.ncbi.nlm.nih.gov/PMC9319350
https://doaj.org/article/a48d1303c72f4751ade88f807a41a02b
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2ISReEJ8iMKoDIfGUtamdr8eutFvRMqqJTX2LHNsplTpnalrU8cfxt3GXpNUCb7ykSvyV5u7sO_vud4x9irTRaFgoV2c6cwXqb27s59w1vVhnItKoxdKGfnIZnF-LrzN_dsD8XSxM5bSvssWJXd6e2MWPyrfy7lZ1d35i3WkyjJFvuN_rHrJDXH53Jno9_QZk7tUQQhzt-e5Pj0wWX1C2PU4p9HxKIPNgDaqg-v-dkP92knyw6oyfsaeNugiD-rWeswNjX7DHdQLJ-5fs92jbOLJaKHKQMMZlqt7dg2TrwZRQGBYWJiWMSgozQm4DVFMB1T4YVH6x99TwanLmTmAwLwhHl1rhx1_K7aKEdUG3FKwHU-zLrkFaDReFnbsXsiSf6XqQalTAoSQkxaY0QEnWltT3pE6D8kvCAG4Wq01JT-r6r9j1ePR9eO42GRlcJQRfu5zQ9_NAolnbRzLmqOtxHefGKBHIPMtyOuRDuzSmneAcVTvUNwLUEehsUfaygL9mR7aw5g0DzSPpY0eSB0ooOn8MpYpDnhmh0VwPHPZxR6P0rgbeSNFgIZqme5o67JSot69AWNnVg2I1TxuOSSWyHK3UKuznIvQ9qU0U5RGOJzzZ62cO-0y0T0mikdJKNoEJ-J6EjZUOKC8bj9Duc9hxqyZKomoX77gnbWaCMqVI4V6VH8xhH_bF1JK826xBklAdv0_QgZ7DwhbXtf5ZuwSFo0IDb4Th7X-3fMee9Cmmg9BC_WN2tF5tzHvUtNZZB-VrFnbYo9PR5fQKf4ffbiZfOtW-BV7PZh5eExF1Kgn8AypYMZU
link.rule.ids 230,314,727,780,784,864,885,2102,2221,12056,21388,24318,27924,27925,31719,31720,33744,33745,38516,43310,43805,43895,53791,53793,73745,74302,74412
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9NADD9BJwQviE-RbYBBSDydluSSNHlCGWppoK2qaUN7iy65S6k0XUaToo4_jr8NO0nLAhKPyX21sc9n--yfGXsXKq3QsMi5ylTGPdTfeOQXgms7UpkXKtRiyaE_mweTC-_zpX_ZOdyqLqxyJxMbQa3KnHzkJ5RxaTd1lj5cf-dUNYpuV7sSGnfZASGn-wN2cDqaL852sjgg26_FExJo3J_8cMh-8amWyq1TqAHr_1ck_x0meevcGT9iDzuFEeKWwo_ZHW2esHttCcmbp-zXaNuFshooC5AwxoOq9e_BbOvAgnAYVgaSCkYVJRohvwEqqoCKH8RNZOwNDTxLPvEE4mVJSLo0Cj__ldyuKqhLeqR0PVjgXKYGaRRMS7PkU1lR1HS7SLMq4FISZuWm0kBl1q5o7qQthPJTQgxfV-tNRW_a_s_YxXh0_nHCu5oMPPc8UXNB-PtFINGwdZGQBWp7QkWF1rkXyCLLCrrmQ8s0Il9wgcodahwBagl0uyjtLBDP2cCURr9goEQofZxIiiD3crqBHMocKZxpT6HBHljs7Y5G6XULvZGiyUKETPeEtNgpUW_fgdCymxflepl2my-VyHR0VudDt_CGviOVDsMixPU8R9puZrH3RPuU9jRSOpddagL-TkLHSmOqzCZCtPwsdtzriXsx7zfvuCftZEGV_uFci73ZN9NIim8zGklCfXyXwAMdiw17XNf7Z_0Ws_rW4IFHKEaFbx_-f_HX7P7kfDZNp8n8yxF74FIaBwGE-sdsUK83-iUqV3X2qttBvwHZCCYa
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegE4gXxKcIG3AgJJ6s5rvJE8qgZYG2qiaG9hY5sV0qTcnWpKjjj-Nv4y5xywISj4m_Ev3s85199zvG3kZSSTQsCi5zmXMf9TceB9rjyo5l7kcStVg60J_Nw5Mz__N5cG78n2rjVrmTia2gllVBZ-RDiri02zxLQ23cIhYfJ-8vrzhlkKKbVpNO4zY7wF3Rdgfs4Hg8X5zu5HJIdmDHLeShoT_84ZAtE1BelRs7Ukvc_694_ttl8sYeNHnA7hvlEZIO7YfsliofsTtdOsnrx-zXeGvcWkuoNAiY4KbVnfXBbOvAgjgZViWkNYxrCjrCuQeotAIqgZC0XrLX1PA0_cRTSJYVsepSK4TiQmxXNTQVPVLoHiywr7IBUUqYVuWST0VNHtTdIO2ogEMJmFWbWgGlXLugvtMuKcpPAQl8W603Nb3p6j9hZ5Px1w8n3ORn4IXvew33iItfhwKNXBdB1aj5eTLWShV-KHSea7ryQys1pnNhjYoeah8hagx00yjsPPSeskFZleoZA-lFIsCOhBcWfkG3kSNRINq58iUa76HF3uwwyi47Go4MzRcCMtsDabFjQm9fgZiz2xfVepmZhZgJnIC0bxcjV_ujwBFSRZGOcDzfEbabW-wdYZ_R-kakC2HCFPA7iSkrSyhLmxehFWixo15NXJdFv3g3ezIjF-rszyy22Ot9MbUkX7dSISRUJ3CJSNCx2Kg363p_1i8pV99bbvAYRaoX2M__P_grdhcXTzZN518O2T2XIjqIKzQ4YoNmvVEvUM9q8pdmAf0Gev8qRw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+of+a+Functional+Mx1+Protein+Is+Essential+for+the+Ability+of+RIG-I+Agonist+Prophylaxis+to+Provide+Potent+and+Long-Lasting+Protection+in+a+Mouse+Model+of+Influenza+A+Virus+Infection&rft.jtitle=Viruses&rft.au=Schwab%2C+Lara+S+U&rft.au=Villal%C3%B3n-Letelier%2C+Fernando&rft.au=Tessema%2C+Melkamu+B&rft.au=Londrigan%2C+Sarah+L&rft.date=2022-07-15&rft.pub=MDPI+AG&rft.eissn=1999-4915&rft.volume=14&rft.issue=7&rft.spage=1547&rft_id=info:doi/10.3390%2Fv14071547&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4915&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4915&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4915&client=summon